The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy-Reference-Cited by-同舟云学术

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

Published:2021-07 Issue:7 Volume:16 Page:1200-1210
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lindberg Karin,Grozman Vitali,Karlsson Kristin,Lindberg Sara,Lax Ingmar,Wersäll Peter,Persson Gitte Fredberg,Josipovic Mirjana,Khalil Azza Ahmed,Moeller Ditte Sloth,Nyman Jan,Drugge Ninni,Bergström Per,Olofsson Jörgen,Rogg Lotte Victoria,Ramberg Christina,Kristiansen Charlotte,Jeppesen Stefan Starup,Nielsen Tine Bjørn,Lödén Britta,Rosenbrand Hans-Olov,Engelholm Silke,Haraldsson André,Billiet Charlotte,Lewensohn Rolf

Funder

Stockholm County Council

Cancer Research Foundations of Radiumhemmet

Swedish Cancer Society

Swedish Medical Association

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009

2. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009